特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ニューロモデュレーションデバイスの世界市場:深部脳刺激(DBS)、脊髄刺激(SCS)、迷走神経刺激(VNS)、仙骨神経刺激(SNS)、胃電気刺激(GES)、その他の用途(2020年~2030年)

Global Neuromodulation Devices Report 2020-2030: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

発行 Visiongain Ltd 商品コード 940965
出版日 ページ情報 英文 238 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=142.71円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

ニューロモデュレーションデバイスの世界市場:深部脳刺激(DBS)、脊髄刺激(SCS)、迷走神経刺激(VNS)、仙骨神経刺激(SNS)、胃電気刺激(GES)、その他の用途(2020年~2030年) Global Neuromodulation Devices Report 2020-2030: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications
出版日: 2020年04月30日 ページ情報: 英文 238 Pages
概要

ニューロモデュレーションデバイス市場は、予測期間中に12.1%のCAGRで成長すると予測されています。

当レポートは世界のニューロモデュレーションデバイス市場について調査しており、業界の動向、市場機会や課題、技術・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 レポートの概要

第2章 ニューロモデュレーションの概要

  • ニューロモデュレーション
  • ニューロモデュレーションの技術
    • 電気刺激技術
    • 薬理療法
  • ニューロモデュレーションの用途
    • 疼痛
    • うつ病
    • てんかん
    • 便失禁および尿失禁
    • 聴覚障害-重度の難聴
    • 心血管疾患-不整脈と狭心症

第3章 世界市場(2019年~2030年)

  • ニューロモデュレーションデバイス市場
  • タイプ別:市場予測
  • 地域別:市場予測
  • 業界の動向
    • 高齢化人口
    • 慢性疾患の有病率の上昇
    • 個別化ヘルスケア
    • 国内規制
    • 世界の政治的不確実性とセキュリティリスク
    • 経済的課題
    • 合併と買収

第4章 市場分析:脊髄刺激

  • 市場概要
  • 市場予測:2019年~2030年
  • 2018年のベストセラー・パイプラインデバイス
  • 用途
  • 市場動向:2019年~2030年

第5章 市場分析:深部脳刺激

第6章 市場分析:胃電気刺激

第7章 市場分析:迷走神経刺激

第8章 市場分析:仙骨神経刺激

第9章 市場分析:その他の技術

  • 市場概要
    • 三叉神経刺激
    • 人工内耳
    • 経頭蓋磁気刺激(TMS)
    • 経頭蓋直流刺激(tDCS)
    • 超音波神経調節
  • 技術予測

第10章 北米

第11章 ラテンアメリカ

第12章 欧州

第13章 アジア太平洋地域

第14章 その他の地域

  • 中東
  • アフリカ

第15章 市場分析:メーカー

  • Medtronic
  • Boston Scientific Corporation
  • Abbott Laboratories
  • LivaNova PLC
  • その他の企業
    • Nevro Corp.
    • SetPoint Medical
    • Functional Neuromodulation
    • WISE Srl
    • SceneRay
    • Aleva Neurotherapeutics SA
    • BioControl Medical
    • SPR Therapeutics
    • Axonics Modulation Technologies, Inc.
    • NeuroPace Inc.

第16章 調査インタビュー

第17章 市場の定性分析

  • SWOT分析
    • 市場の強み
    • 市場の弱点
    • 市場の機会
    • 市場の脅威
  • STEP分析
  • 臨床検査参加の企業のスナップショット

第18章 結論

図表

List of Tables

  • Table 3.1 Global Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 3.2 Global Neuromodulation Devices Market by region: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 4.1 SCS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 4.2 Leading & Pipeline SCS Devices, 2018
  • Table 5.1 DBS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 5.2 Leading & Pipeline DBS Devices, 2018
  • Table 6.1 GES Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 6.2 Leading GES Devices, 2018
  • Table 7.1 VNS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 7.2 Leading VNS & Pipeline Devices, 2018
  • Table 8.1 SNS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 8.2 Leading & Pipeline SNS Devices, 2018
  • Table 9.1 Leading & Pipeline Other Neuromodulation Devices, 2018
  • Table 9.2 Other Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 10.1 North American Neuromodulation Devices Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 10.2 North American Neuromodulation Devices Market by type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 10.3 The US Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 10.4 The Canadian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 11.1 Latin American Neuromodulation Devices Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 11.2 Latin American Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 11.3 The Brazilian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 11.4 The Mexican Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 11.5 The Argentina Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 11.5 The rest of Latin America Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 12.1 European Neuromodulation Devices Market by Country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 12.2 European Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 12.3 The German Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 12.4 The French Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 12.5 The UK Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 12.6 The Italian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 12.7 The Spanish Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 12.8 The Russian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 12.8 The Netherlands Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 12.8 Switzerland Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 12.8 Belgium Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 12.8 Austria Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 12.9 The rest of European Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 13.1 Asia-Pacific Neuromodulation Devices Market, by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 13.2 Asia-Pacific Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 13.3 The Japanese Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 13.4 The Chinese Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 13.5 The Indian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 13.6 The Australian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 13.7 The South-Korean Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 13.8 The rest of Asia-Pacific Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 14.1 Rest of the world Neuromodulation Devices Market by Country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 14.2 Rest of the world Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 14.3 The Middle-Eastern Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 14.4 The African Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2030
  • Table 17.1 Companies in Active Clinical Trials 2019-2030

List of Figures:

  • Figure 1.1 Neuromodulation Devices Market Segmentation, 2019
  • Figure 3.1 Global Neuromodulation Devices Market by Type: Market Share (%) 2020
  • Figure 3.2 Global Neuromodulation Devices Market by Type: Market Share (%) 2030
  • Figure.3.3 Global Neuromodulation Devices Market by Region: Market Share (%) 2020
  • Figure 3.4 Global Neuromodulation Devices Market by Country: Market Share (%) 2030
  • Figure 3.5 Global Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 3.6 Global Neuromodulation Devices Market: Drivers and Restraints
  • Figure 4.1 SCS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019- 2030
  • Figure 5.1 DBS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019- 2030
  • Figure 6.1 GES Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019- 2030
  • Figure 7.1 VNS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019- 2030
  • Figure 8.1 SNS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019- 2030
  • Figure 9.1 Other Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019- 2030
  • Figure 10.1 North American Neuromodulation Devices Market by Country: Market Share (%) 2020
  • Figure 10.2 North American Neuromodulation Devices Market by Country: Market Share (%) 2030
  • Figure 10.3 North American Neuromodulation Devices Market by Type: Market Share (%) 2020
  • Figure 10.4 North American Neuromodulation Devices Market by Type: Market Share (%) 2030
  • Figure 10.5 North American Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 10.6 The US Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 10.7 The Canadian Neuromodulation Devices Market Revenue Forecast ($m) AGR (%), 2019-2030
  • Figure 11.1 Latin American Neuromodulation Devices Market by Country: Market Share (%) 2020
  • Figure 11.2 Latin American Neuromodulation Devices Market by Country: Market Share (%) 2030
  • Figure 11.3 Latin American Neuromodulation Devices Market by Type: Market Share (%) 2020
  • Figure 11.4 Latin American Neuromodulation Devices Market by Type: Market Share (%) 2030
  • Figure 11.5 Latin American Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 11.6 The Brazilian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030 Fig 11.7 The Mexican Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 11.8 The Argentina Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 11.8 The rest of Latin America Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 12.1 European Neuromodulation Devices Market by Country: Market Share (%) 2020
  • Figure 12.2 European Neuromodulation Devices Market by Country: Market Share (%) 2030
  • Figure 12.3 European Neuromodulation Devices Market by Type: Market Share (%) 2020
  • Figure 12.4 European Neuromodulation Devices Market by Type: Market Share (%) 2030
  • Figure 12.5 European Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 12.6 The German Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 12.7 The French Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 12.8 The UK Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 12.9 The Italian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 12.10 The Spanish Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 12.11 The Russian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 12.11 The Netherlands Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 12.11 Switzerland Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 12.11 Belgium Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 12.11 Austria Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 12.12 The rest of European Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 13.1 Asia-Pacific Neuromodulation Devices Market by Country: Market Share (%) 2020
  • Figure 13.2 Asia-Pacific Neuromodulation Devices Market by Country: Market Share (%) 2030
  • Figure 13.3 Asia-Pacific Neuromodulation Devices Market by Type: Market Share (%) 2020
  • Figure 13.4 Asia-Pacific Neuromodulation Devices Market by Type: Market Share (%) 2030
  • Figure 13.5 Asia-Pacific Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 13.6 The Japanese Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure13.7 The Chinese Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 13.8 The Indian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 13.9 The Australian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 13.10 The South-Korean Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 13.11 The rest of Asia-Pacific Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 14.1 Rest of the world Neuromodulation Devices Market by Country: Market Share (%) 2020
  • Figure 14.2 Rest of the world Neuromodulation Devices Market by Country: Market Share (%) 2030
  • Figure 14.3 Rest of the world Neuromodulation Devices Market by Type: Market Share (%) 2020
  • Figure 14.4 Rest of the world Neuromodulation Devices Market, by type: Market Share (%) 2030
  • Figure 14.5 Rest of the world Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 14.6 The Middle-Eastern Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 14.7 The African Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2019-2030
  • Figure 15.1 Neuromodulation Devices Market: Market Share Analysis, 2019
  • Figure 15.2 Medtronic Revenue ($m), 2015-2019
  • Figure 15.3 Medtronic Operating Sectors (%), 2017
  • Figure 15.4 Medtronic Sales Shares (%), 2017
  • Figure 15.5 Boston Scientific Revenues ($m), 2015-2019
  • Figure 15.6 Boston Scientific Operating Segments (%), 2019
  • Figure 15.9 Boston Scientific Geographical Sales Shares (%), 2019
  • Figure 15.12 Abbott Revenues ($m), 2015-2019
  • Figure 15.13 Abbott Operating Segments (%), 2019
  • Figure 15.15 Abbott World Sales Shares (%), 2019
  • Figure 15.16 LivaNova Company Revenues ($m), 2015-2019
  • Figure 15.17 LivaNova Company Operating Segments (%) (2019)
  • Figure 15.18 LivaNova World Sales for Neuromodulation Devices Shares (%), 2019
  • Figure 15.19 Nevro Corp. Revenue ($m), 2015-2019
  • Figure 15.20 Nevro Corp. Revenue ($m), by Geography (%), 2019
  • Figure 17.1 SWOT Analysis of the Neuromodulation Devices Market, 2020
  • Figure 17.2 STEP Analysis of the Neuromodulation Devices Market, 2020

List of Companies Mentioned in the Report:

  • Abbott Laboratories
  • Advanced Uro-Solutions
  • Aleva Neurotherapeutics
  • Atrotech
  • Autonomic Technologies
  • Avery Biomedical
  • Axonics Modulation
  • BioControl Medical
  • Bioness, Inc.
  • BlueWind
  • Boston Scientific
  • CardioMEMS
  • CerebralRx
  • CerebroMed
  • Cogentix Medical
  • Covidien
  • CVRx, Inc
  • Deep Brain Innovations
  • Dymedix Corporation
  • ElectroCore INC
  • EndoNovo
  • EnteroMedics
  • Functional Neuromodulation
  • Genesys Capital
  • GlaxoSmithKline
  • Greatbatch
  • Halo Neuroscience
  • ImThera Medical
  • InCube Labs
  • InSightec
  • Integer Holdings Corporation
  • Jens Brondum Frokjar
  • Laborie Medical Technologies
  • Lake Region Medical
  • LivaNova
  • MagStim
  • MainStay Medical
  • Mayo Clinic
  • Medtronic
  • Medtronic Eindhoven Design Centre (MEDC)
  • Medtronic France SAS
  • MedtronicNeuro
  • MetaCure
  • Microtransponder
  • Mindray
  • MyndTec Inc.
  • Nanostim
  • NDI Medical
  • NeuImpulse
  • Neuromod Devices Ltd
  • NeuroPace
  • NeuroSigma
  • NeuroStar
  • Neurotherapies Reset
  • NeuroTherm
  • NeuroVista Corp
  • NeuSpera
  • Nevro
  • Newronika
  • Nexstim plc
  • Northwell Health
  • nUro Inc
  • Nuvectra Corporation
  • QiG Group,LLC
  • SceneRay
  • Scion NeuroStim
  • SetPoint Medical
  • SorinSpA
  • Soterix Medical
  • Spinal Modulation Inc
  • SPR Therapeutics
  • St. Jude Medical
  • Stimwave
  • Synapse Medical
  • The Neuroscience Center, LLC
  • Theranova, L.L.C.
  • TriHealth Inc.
  • Urolplasty

List of Companies Mentioned in the Report:

  • Aalborg University Hospital
  • Australia Institute of Health and Welfare
  • China Food and Drug Administration (CFDA)
  • Dutch National Health Care Institute
  • Food and Drug Administtration (FDA)
  • Foundation Medical Partners
  • Gaceta Medica de Mexico
  • Genesys Capital
  • Health Canada
  • Maastricht University Medical Center
  • National Institute for Health and Care Excellence (NICE)
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • Nordic Neuromodulation Society
  • North American Neuromodulation Society (NANS)
  • Northern California Institute of Research and Education
  • Organization for Economic Cooperation and Development (OECD)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • University Hospital Regensburg
  • World Health Organization (WHO)
目次
Product Code: PHA0715

The neuromodulation devices market is estimated to grow at a CAGR of 12.1% over the forecast period.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 238-page report you will receive 130 charts- all unavailable elsewhere.

The 238-page report provides clear detailed insight into the global neuromodulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Neuromodulation Devices market forecasts from 2020-2030.

This report also breaks down the revenue forecast for the global neuromodulation devices market by type:

  • Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS)
  • Vagus Nerve Stimulation (VNS)
  • Sacral Nerve Stimulation (SNS)
  • Gastric Electrical Stimulation (GES)
  • Other Applications

This report discusses the market trends and lists the leading products/pipeline products of each submarket.

This report provides individual revenue forecasts to 2030 for these regional and national markets:

  • North America: the US and Canada
  • Europe: France, Germany, Italy, U.K, Spain, Russia, Netherlands, Switzerland, Belgium, Austria, Rest of Europe
  • Asia-Pacific: Japan, China, India, Australia, South Korea and rest of Asia-Pacific
  • Latin America: Brazil, Mexico, Argentina, Rest of Latin America
  • Rest of the World: Middle East, Africa

Each regional market is further segmented by type of applications: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

Our study gives qualitative analysis of the neuromodulation devices market. It discusses the factors that drive and restrain the neuromodulation devices market. This study also provides a SWOT and STEP analysis.

Our study discusses the selected leading companies that are the major players in the neuromodulation devices industry:

  • Medtronic
  • Boston Scientific
  • Abbott Laboratories
  • LivaNova PLC
  • & Other Companies

Visiongain's study is intended for anyone requiring commercial analyses for the global neuromodulation devices market. You find data, trends and predictions.

Buy our report today Global Neuromodulation Devices Report 2020-2030: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Overview of the World Market for Neuromodulation Devices
  • 1.2 Why You Should Read This Report
  • 1.3 How this Report Delivers
  • 1.4 Main Questions Answered by this Analysis
  • 1.5 Who is this Report For?
  • 1.6 Methodology
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2. Introduction to Neuromodulation

  • 2.1 Neuromodulation
  • 2.2 Techniques Used in Neuromodulation
    • 2.2.1 Electrical Stimulation Techniques
    • 2.2.2 Pharmacological Therapy
  • 2.3 Application of Neuromodulation
    • 2.3.1 Pain
    • 2.3.2 Depression
    • 2.3.3 Epilepsy
    • 2.3.4 Faecal and Urinary Incontinence
    • 2.3.5 Hearing Disorders - Profound Deafness
    • 2.3.6 Cardiovascular Diseases - Arrhythmia and Angina

3. Global Neuromodulation Devices Market 2019-2030

  • 3.1 Neuromodulation Devices Market: 2019
  • 3.2 Neuromodulation Devices Market Forecast by Type: 2019-2030
  • 3.3 Neuromodulation Devices Market Forecast by Region: 2019-2030
  • 3.4 Neuromodulation Devices: Industry Trends, 2019-2030
    • 3.4.1 Industry Trends - Ageing Population
    • 3.4.2 Rising Prevalence of Chronic Diseases
    • 3.4.3 Industry Trends - Personalised Healthcare
    • 3.4.4 Industry Trends - National Regulations
    • 3.4.5 Political Uncertainty and Security Risk across the World
    • 3.4.6 Industry Trends - Economic Challenges
    • 3.4.7 Industry Trends - Mergers and Acquisitions

4. Spinal Cord Stimulation Submarket, 2019-2030

  • 4.1 Spinal Cord Stimulation (SCS) Market Overview, 2019
  • 4.2 SCS Market Forecast: 2019-2030
  • 4.3 Top Selling & Pipeline SCS Devices, 2018
  • 4.4 Applications of Spinal Cord Stimulation
  • 4.5 SCS Market Trends: 2019-2030

5. Deep Brain Stimulation Submarket, 2019-2030

  • 5.1 Deep Brain Stimulation (DBS) Market Overview, 2019
  • 5.2 DBS Market Forecast: 2019-2030
  • 5.3 Top Selling & Pipeline DBS Devices, 2018
  • 5.4 Applications of Deep Brain Stimulation
  • 5.5 DBS Market Trends: 2019-2030

6. Gastric Electrical Stimulation Submarket, 2019-2030

  • 6.1 Gastric Electrical Stimulation (GES) Market Overview, 2019
  • 6.2 GES Market Forecast: 2019-2030
  • 6.3 Top Selling GES Devices, 2018
  • 6.4 Applications of Gastric Electrical Stimulation
  • 6.5 GES Market Trends: 2019-2030

7. Vagus Nerve Stimulation Submarket, 2019-2030

  • 7.1 Vagus Nerve Stimulation (VNS) Market Overview, 2019
  • 7.2 VNS Market Forecast: 2019-2030
  • 7.3 Top Selling & Pipeline VNS Devices, 2018
  • 7.4 Applications of Vagus Nerve Stimulation
  • 7.5 VNS Market Trends: 2019-2030

8. Sacral Nerve Stimulation Submarket, 2019-2030

  • 8.1 Sacral Nerve Stimulation (SNS) Market Overview, 2019
  • 8.2 SNS Market Forecast: 2019-2030
  • 8.3 Top Selling & Pipeline SNS Devices, 2018
  • 8.4 Applications of Sacral Nerve Stimulation
  • 8.5 SNS Market Trends: 2019-2030

9. Other Neuromodulation Technologies Submarket, 2019-2030

  • 9.1 Other Neuromodulation Technologies Overview, 2019
    • 9.1.1 Trigeminal Nerve Stimulation
    • 9.1.2 Cochlear Implants
    • 9.1.3 Transcranial Magnetic Stimulation (TMS)
    • 9.1.4 Transcranial Direct Current Stimulation (tDCS)
    • 9.1.5 Ultrasonic Neuromodulation
  • 9.2 Other Neuromodulation Techniques Forecast: 2019-2030

10. North American Neuromodulation Devices Market 2019-2030

  • 10.1 Overview: North American Neuromodulation Devices Market 2019
  • 10.2 The US Neuromodulation Devices Market: 2019-2030
    • 10.2.1 The US Neuromodulation Devices Market Forecast: 2019-2030
  • 10.3 The Canadian Neuromodulation Devices Market: 2019-2030
    • 10.3.1 The Canadian Neuromodulation Devices Market Forecast: 2019-2030

11. Latin American Neuromodulation Devices Market 2019-2030

  • 11.1 Overview: Latin American Neuromodulation Devices Market 2019
  • 11.2 The Brazilian Neuromodulation Devices Market: 2019-2030
    • 11.2.1 The Brazilian Neuromodulation Devices Market: Economic and Political Challenges Affecting Prospects
    • 11.2.2 The Brazilian Neuromodulation Devices Market Forecast: 2019-2030
  • 11.3 The Mexican Neuromodulation Devices Market: 2019-2030
    • 11.3.1 The Mexican Neuromodulation Devices Market Forecast: 2019-2030
  • 11.4 The Argentina Neuromodulation Devices Market: 2019-2030
    • 11.4.1 The Argentina Neuromodulation Devices Market Forecast: 2019-2030
  • 11.5 The rest of Latin America Neuromodulation Devices Market: 2019-2030
    • 11.5.1 The rest of Latin America Neuromodulation Devices Market Forecast: 2019-2030

12. European Neuromodulation Devices Market 2019-2030

  • 12.1 Overview: European Neuromodulation Devices Market 2019
  • 12.2 The German Neuromodulation Devices Market: 2019-2030
    • 12.2.1 The German Neuromodulation Devices Market Forecast: 2019-2030
  • 12.3 The French Neuromodulation Devices Market: 2019-2030
    • 12.3.1 The French Neuromodulation Devices Market - the Economy and its Implications
    • 12.3.2 The French Neuromodulation Devices Market Forecast: 2019-2030
  • 12.4 The UK Neuromodulation Devices Market: 2019-2030
    • 12.4.1 The UK Neuromodulation Devices Market Forecast - Political Challenges
    • 12.4.2 The UK Neuromodulation Devices Market Forecast: 2019-2030
  • 12.5 The Italian Neuromodulation Devices Market: 2019-2030
    • 12.5.1 The Italian Neuromodulation Devices Market Outlook
    • 12.5.2 The Italian Neuromodulation Devices Market Forecast: 2019-2030
  • 12.6 The Spanish Neuromodulation Devices Market: 2019-2030
    • 12.6.1 The Spanish Neuromodulation Devices Market Forecast: 2019-2030
  • 12.7 The Russian Neuromodulation Devices Market: 2019-2030
    • 12.7.1 The Russian Neuromodulation Devices Market Forecast: 2019-2030
    • 12.8.1 The Netherlands Neuromodulation Devices Market Forecast: 2019-2030
  • 12.9 Switzerland Neuromodulation Devices Market: 2019-2030
    • 12.9.1 Switzerland Neuromodulation Devices Market Forecast: 2019-2030
  • 12.10 Belgium Neuromodulation Devices Market: 2019-2030
    • 12.10.1 Belgium Neuromodulation Devices Market Forecast: 2019-2030
  • 12.11 Austria Neuromodulation Devices Market: 2019-2030
    • 12.11.1 Austria Neuromodulation Devices Market Forecast: 2019-2030
  • 12.12 The rest of European Neuromodulation Devices Market: 2019-2030
    • 12.8.1 The rest of European Neuromodulation Devices Market Forecast: 2019-2030

13. Asia-Pacific Neuromodulation Devices Market 2019-2030

  • 13.1 Overview: Asia-Pacific Neuromodulation Devices Market 2019
  • 13.2 The Japanese Neuromodulation Devices Market: 2019-2030
    • 13.2.1 The Japanese Neuromodulation Devices Market -Regulation Effects
    • 13.2.2 The Japanese Neuromodulation Devices Market Forecast: 2019-2030
  • 13.3 The Chinese Neuromodulation Devices Market: 2019-2030
    • 13.3.1 The Chinese Neuromodulation Devices Market - Amendments to Regulations
    • 13.3.2 The Chinese Neuromodulation Devices Market Forecast: 2019-2030
  • 13.4 The Indian Neuromodulation Devices Market: 2019-2030
    • 13.4.1 The Indian Neuromodulation Devices Market Forecast: 2019-2030
  • 13.5 The Australian Neuromodulation Devices Market: 2019-2030
    • 13.5.1 The Australian Neuromodulation Devices Market Forecast: 2019-2030
  • 13.6 The South-Korean Neuromodulation Devices Market: 2019-2030
    • 13.6.1 The South-Korean Neuromodulation Devices Market Forecast: 2019-2030
  • 13.7 The rest of Asia-Pacific Neuromodulation Devices Market: 2019-2030
    • 13.7.1 The rest of Asia-Pacific Neuromodulation Devices Market Forecast: 2019-2030

14. Rest of the World Neuromodulation Devices Market 2019-2030

  • 14.1 Overview: Rest of the World Neuromodulation Devices Market 2019
  • 14.2 The Middle-Eastern Neuromodulation Devices Market: 2019-2030
    • 14.2.1 The Middle-Eastern Neuromodulation Devices Market Forecast: 2019-2030
  • 14.3 The African Neuromodulation Devices Market: 2019-2030
    • 14.3.1 The African Neuromodulation Devices Market Forecast: 2019-2030

15. Neuromodulation Devices Market: Manufacturers

  • 15.1 Medtronic
    • 15.1.1 Sales and Recent Performance Analysis, 2017
    • 15.1.2 Medtronic International Operations
    • 15.1.3 Medtronic News
    • 15.1.4 Medtronic Market Outlook
  • 15.2 Boston Scientific Corporation
    • 15.2.1 Sales and Recent Performance Analysis: 2019
    • 15.2.2 Boston Scientific International Operations
    • 15.2.3 Boston Scientific News
    • 15.2.4 Boston Scientific Market Outlook
  • 15.3 Abbott Laboratories
    • 15.3.1 Sales and Recent Performance Analysis: 2019
    • 15.3.2 Abbott International Operations, 2019
    • 15.3.3 Abbot/ SJM News
    • 15.3.4 SJM - Market Outlook
  • 15.4 LivaNova PLC
    • 15.4.1 Sales and Recent Performance Analysis: 2019
    • 15.4.2 LivaNova Company International Operations
    • 15.4.3 LivaNova News
    • 15.4.4 LivaNova Market Outlook
  • 15.5 Other Companies
    • 15.5.1 Nevro Corp.
    • 15.5.2 SetPoint Medical
    • 15.5.3 Functional Neuromodulation
    • 15.5.4 WISE Srl
    • 15.5.5 SceneRay
    • 15.5.6 Aleva Neurotherapeutics SA
    • 15.5.7 BioControl Medical
    • 15.5.8 SPR Therapeutics
    • 15.5.9 Axonics Modulation Technologies, Inc.
    • 15.5.10 NeuroPace Inc.

16. Research Interviews

  • 16.1 Dr. Robert Levy, President, International Neuromodulation Society
  • 16.2 International Neuromodulation Society
  • 16.3 Current Neuromodulation Landscape
  • 16.4 Patient Needs
  • 16.5 Regulation of Neuromodulation Devices
  • 16.6 Future of Neuromodulation

17. Qualitative Analysis of the Neuromodulation Devices Market

  • 17.1 SWOT Analysis of the Neuromodulation Devices Market
    • 17.1.1 Strengths of the Market
    • 17.1.2 Weaknesses
    • 17.1.3 Opportunities in the Neuromodulation Devices Market
    • 17.1.4 Threats Facing the Neuromodulation Devices Market
  • 17.2 STEP Analysis of the Neuromodulation Devices Market
    • 17.2.1 Social Factors: The Role of Neuroethics
    • 17.2.2 Technological Developments: Drive towards Non-Invasive Methods
    • 17.2.3 Economic Restraints: High Production Costs
    • 17.2.4 Economic Potential: Emerging Markets Create Demand
    • 17.2.5 Political Issues: Strong Government Influence
  • 17.3 Snapshot of Companies in Active Clinical Trials
    • 17.3.1 Neuromodulation Pipeline Products -2016-2018

18. Conclusions

  • 18.1 The United States Retains its Position as Market Leader
  • 18.2 Growing Incidences of Neurological Diseases
  • 18.3 Ageing Population Drives Growth
  • 18.4 China and India will lead the Emerging Markets
  • 18.5 The Future of the Market - Deep Brain Stimulation and Vagus Nerve Stimulation
  • 18.6 Concluding Remarks
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain Report Evaluation Form